Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens

被引:66
作者
Carrillo-Conde, Brenda [1 ]
Schiltz, Elise [1 ]
Yu, Jing [2 ]
Minion, F. Chris [2 ]
Phillips, Gregory J. [2 ]
Wannemuehler, Michael J. [2 ]
Narasimhan, Balaji [1 ]
机构
[1] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA
[2] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA
基金
美国国家科学基金会;
关键词
Proteins; Antigens; Microparticles; Polyanhydride; Stability; PROTECTIVE EFFICACY; PROTEIN AGGREGATION; PNEUMONIC PLAGUE; BUBONIC PLAGUE; FUSION PROTEIN; DRUG-DELIVERY; MICROSPHERES; RELEASE; PRODUCTS; VACCINE;
D O I
10.1016/j.actbio.2010.01.040
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
The design of biodegradable polymeric delivery systems based on polyanhydrides that would provide for improved structural integrity of Yersinia pesos antigens was the main goal of this study Accordingly, the full-length Y pesos fusion protein (F1-V) or a recombinant Y pesos fusion protein (F1(B2T1)-V10) was encapsulated and released from microparticles based on 1,6-bis(p-carboxyphenoxy)hexane (CPH) and sebacic acid (SA) copolymers and 1,8-bis(p-carboxyphenoxy)-3,6-dioxaoctane (CPTEG) and CPH copolymers fabricated by cryogenic atomization. An enzyme-linked immunosorbent assay was used to measure changes in the antigenicity of the released proteins The recombinant F1(B2T1)-V10 was unstable upon release from the hydrophobic CPH SA microparticles. but maintained its structure and antigenicity in the amphiphilic CPTEG CPH system The full-length F1-V was stably released by both CPH SA and CPTEG CPH microparticles. In order to determine the effect of the anhydride monomers on the protein structure, changes in the primary, secondary, and tertiary structure, as well as the antigenicity of both Y pestis antigens, were measured after incubation in the presence of saturated solutions of SA. CPH, and CPTEG anhydride monomers The results indicated that the amphiphilic environment provided by the CPTEG monomer was Important to preserve the structure and antigenicity of both proteins These studies offer an approach by which a thorough understanding of the mechanisms governing antigenic instability can be elucidated in order to optimize the in vivo performance of biodegradable delivery devices as protein carriers and/or vaccine adjuvants (C) 2010 Acta Materialia Inc Published by Elsevier Ltd All rights reserved
引用
收藏
页码:3110 / 3119
页数:10
相关论文
共 45 条
[1]
Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice [J].
Anderson, GW ;
Heath, DG ;
Bolt, CR ;
Welkos, SL ;
Friedlander, AM .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 58 (06) :793-799
[2]
Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis [J].
Anderson, GW ;
Leary, SEC ;
Williamson, ED ;
Titball, RW ;
Welkos, SL ;
Worsham, PL ;
Friedlander, AM .
INFECTION AND IMMUNITY, 1996, 64 (11) :4580-4585
[3]
Sustained delivery of proteins for novel therapeutic products [J].
Bartus, RT ;
Tracy, MA ;
Emerich, DF ;
Zale, SE .
SCIENCE, 1998, 281 (5380) :1161-1162
[4]
Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles [J].
Bilati, U ;
Allémann, E ;
Doelker, E .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2005, 59 (03) :375-388
[5]
Polyanhydrides: the effects of ring substitution changes on polymer properties [J].
Campo, CJ ;
Anastasiou, T ;
Uhrich, KE .
POLYMER BULLETIN, 1999, 42 (01) :61-68
[6]
CARRILLOCONDE B, J BIOMED MAT A UNPUB
[7]
CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307
[8]
Conix A., 1966, Macromolecule Synthesis, V2, P95
[9]
Stability and release of bovine serum albumin encapsulated within poly(D,L-lactide-co-glycolide) microparticles [J].
Crotts, G ;
Park, TG .
JOURNAL OF CONTROLLED RELEASE, 1997, 44 (2-3) :123-134
[10]
Biophysical Characterization and Formulation of F1-V, a Recombinant Plague Antigen [J].
D'Souza, Ajit Joseph M. ;
Ford, Brandi M. ;
Mar, Kevin D. ;
Sullivan, Vince J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (08) :2592-2602